Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs located in Germany, and U-Medico, an innovative formulation development and biophysical characterizations service provider located in Japan, have formed an alliance that includes an equity investment by Coriolis Pharma into U-Medico. The alliance aims to extend Coriolis Pharma’s expertise, service portfolio and market reach into the Japanese ...